Sensus Healthcare Stock Plummets to New 52-Week Low of $2.68

Sensus Healthcare, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 2.68 as of June 1, 2026. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 47.99% over the past year, contrasting sharply with the S&P 500's performance of 28.56% during the same period. The company's financial metrics indicate ongoing difficulties, with a net profit of -USD 5.79 million, marking a staggering decline of 464.62%. Additionally, Sensus Healthcare has reported negative results for five consecutive quarters, with its return on equity standing at -16.05% and a debt-to-equity ratio of -0.45. The stock's price-to-book ratio is currently at 1.36, suggesting that it is trading at a valuation that may not reflect its underlying financial health. With a market capitalization of USD 65 million and a dividend yield of 0.00%, Sensus Healthcare continues to face significant challenges in both short-term and long-term performance metrics.